To streamline the home testing process, reduce device costs, and expedite patient outcomes, ENT Partners adopted EnsoHST, an FDA-Cleared, AI-Powered Sleep Diagnostic SaMD that leverages data from pulse oximeters.
In the case study, Dr. Herdegen highlights the challenges their team faced with the expansion project, and how EnsoSleep was not only able to help their team cut into the current scoring backlog, but also absorb a second lab’s worth of studies to boot. Dive into the full case study to see how they made it happen.
Four (plus one) sleep trends for 2021: see how one HSAT-focused sleep practice is championing them all.
If complete data interoperability is the future, how do we get there?